Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first line treatment in advanced non-small lung cancer (NSCLC) patients: preliminary results of a prospective study
Authors | |
---|---|
Year of publication | 2009 |
Type | Article in Periodical |
Magazine / Source | Journal of Thoracic Oncology |
MU Faculty or unit | |
Citation | |
Field | Pneumology |
Keywords | Vinorelbine intravenous and oral; carboplatin; first line treatment in advanced non-small lung cancer (NSCLC) patients; preliminary results of a prospective study |
Description | Preliminary results are presented of a prospective trial of intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first line treatment in patients with advanced non-small lung cancer (NSCLC) patients: preliminary results of a prospective study |
Related projects: |